In prostate cancer cell lines, such as LNCaP cells and colon cancer cells SW480, CBD (15 μM) induced apoptosis, increasing the levels of cleaved PARP and caspase-3 mediated by CB1 and CB2 receptors [56]. This evidence concerns the gene CNR1 and prostate carcinoma.